Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021
November 10 2021 - 4:45PM
Centessa Pharmaceuticals plc (“Company”) (Nasdaq: CNTA) today
announced that Saurabh Saha, MD, PhD, Chief Executive Officer, will
present at the following investor conferences:
Event: Jefferies
London Healthcare Conference Date: Thursday,
November 18, 2021Presentation Details: Recording
available on-demand on Thursday, November 18, 2021, starting
at 3:00 AM ET (8:00 GMT)
Event: Evercore ISI
HealthCONx Conference Date: Thursday, December 2,
2021 Fireside Chat Details: 4:20 PM ET (21:20
GMT)
Access to the live webcasts of these
events, as well as archived recordings, will be available under the
“Events” tab on the investor relations section of the Centessa
Pharmaceuticals website
at https://investors.centessa.com/events-presentations.
About Centessa PharmaceuticalsCentessa
Pharmaceuticals plc aims to bring impactful new medicines to
patients by combining the strengths of an asset-centric model with
the benefits of scale and diversification typical of larger R&D
organizations. The asset-centric model refers to a highly
specialized, singular-focused company that is led by a team of
well-recognized subject matter experts. Centessa’s asset-centric
companies’ programs range from discovery-stage to late-stage
development and include diverse therapeutic areas such as oncology,
hematology, immunology/inflammation, neuroscience, hepatology,
pulmonology and nephrology. For more information, visit
www.centessa.com.
Contacts:
Investors:Jennifer Porcelli, Head of Investor
RelationsCentessa
Pharmaceuticalsjennifer.porcelli@centessa.com
Media:1ABDan Budwick
dan@1abmedia.com
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Oct 2023 to Oct 2024